In a rare exemplary work in Indian medical history, doctors at Artemis Hospitals performed the country’s first successful, Bone Marrow Transplant for Hunter Syndrome. Five years old, Mohd. Farhin from Bangladesh underwent the transplant 6 months ago under a team of proficient doctors headed by Dr. Vikas Dua, Consultant – Paediatric BMT & Haemato Oncology, Artemis Hospitals.
Talking about the case, Dr. Vikas Dua, said “Since there’s no cure for Hunter syndrome, the treatment majorly focuses on managing signs, symptoms and complications to provide some respite for the child as the disease progresses. Bone Marrow Transplant for Hunter Syndrome has never been performed in India due to the complicacy and unawareness of the procedure. Bone Marrow Transplant helped in easing the problems of breathing, mobility, as well as heart, liver and spleen functions in Farhin. We are extremely happy that the transplant did wonders and Farhin’s health is improving at the moment.”
Hunter Syndrome, also known as Mucopolysaccharidosis II (MPS II) is a rare X-linked genetic disorder that primarily affects males. It occurs in approximately 1 in 162,000 male live births and is caused by a deficiency or absence of the enzyme iduronate 2-sulfatase (I2S) which results in a build-up of glycosaminoglycans (GAGs) in cells throughout the body. The accumulation of GAGs interferes with the way certain cells and organs in the body function and can lead to a number of serious symptoms including hearing loss, declined cardiac function, obstructive airway disease, and decreased range of mobility. Although, a number of cases of Hunter Syndrome have been reported in India, there has been no treatment discovered for it.